课题基金 / 基金详情

PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT. POP: 9/20/2017-9/19/2022. N01DA-17-8935.

药物开发的药代动力学和药效动力学研究。

批准号：

10038836

负责人：

ELIZABETH POLVENT

金额：

$133.42万

依托单位：

依托单位国家：

美国

项目类别：

财政年份：

2017

资助国家：

美国

项目状态：

已结题

起止时间：

2017-09-20 至 2022-09-19

来源：

https://reporter.nih.gov/project-details/10038836

关键词：

Biological Products Cannabidiol Clinical Pharmacology Contractor Development Disease Drug Interactions Drug Kinetics Enzymes Molecular Monoclonal Antibodies Morphine Pharmaceutical Preparations Phase Tobacco use United States Food and Drug Administration Vaccines cocaine use marijuana use methamphetamine use novel therapeutics opioid abuse opioid use pharmacokinetics and pharmacodynamics stem

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Contractor shall carry out clinical pharmacology/pharmacokinetic studies to support the development of new medications for the treatment of disorders stemming from tobacco, cannabis, cocaine, methamphetamine, or opiate use or abuse. The study medications include new molecular entities, new biological products (monoclonal antibodies, enzymes, vaccines, etc.), new drug products, and drug products approved by the Food and Drug Administration (FDA) for other indications.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文